These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2191038)

  • 41. Expression of IL-18 in psoriasis.
    Ohta Y; Hamada Y; Katsuoka K
    Arch Dermatol Res; 2001 Jul; 293(7):334-42. PubMed ID: 11550806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The pathogenesis of psoriasis--new results].
    Dunkel FG; Burg G
    Fortschr Med; 1992 Sep; 110(25):457-60. PubMed ID: 1383110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinocytes from normal and uninvolved psoriatic skin.
    Kragballe K; Marcelo CL; Voorhees JJ; Sauder DN
    J Invest Dermatol; 1987 Jan; 88(1):8-10. PubMed ID: 3491857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuronal changes in psoriasis exacerbation.
    El-Nour H; Santos A; Nordin M; Jonsson P; Svensson M; Nordlind K; Berg M
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1240-5. PubMed ID: 19453808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin.
    Széll M; Bata-Csörgo Z; Koreck A; Pivarcsi A; Polyánka H; Szeg C; Gaál M; Dobozy A; Kemény L
    J Invest Dermatol; 2004 Sep; 123(3):537-46. PubMed ID: 15304094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology of psoriasis.
    Plummer NA
    Acta Derm Venereol Suppl (Stockh); 1979; 87():51-4. PubMed ID: 231369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes.
    Man XY; Li W; Chen JQ; Zhou J; Landeck L; Zhang KH; Mu Z; Li CM; Cai SQ; Zheng M
    Cell Mol Life Sci; 2013 Jun; 70(12):2205-20. PubMed ID: 23334186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity.
    Karvonen SL; Koivunen J; Nissinen M; Ylä-Outinen H; Björkstrand AS; Peltonen J
    Br J Dermatol; 2004 Feb; 150(2):211-9. PubMed ID: 14996090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids.
    Gruaz D; Didierjean L; Grassi J; Frobert Y; Dayer JM; Saurat JH
    Dermatologica; 1989; 179(4):202-6. PubMed ID: 2695356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CELL PROLIFERATION AND CYTOKINE INDUCTION BY TNF-alpha OF PSORIATIC KERATINOCYTES ARE NOT DIFFERENT FROM NORMAL KERATINOCYTES IN VITRO.
    Takahashi H; Tsuji H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
    Indian J Dermatol; 2009 Jul; 54(3):237-9. PubMed ID: 20161853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a keratinocyte-based screening model for antipsoriatic drugs using green fluorescent protein under the control of an endogenous promoter.
    Pol A; van Ruissen F; Schalkwijk J
    J Biomol Screen; 2002 Aug; 7(4):325-32. PubMed ID: 12230886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.
    Gillitzer R; Berger R; Mielke V; Müller C; Wolff K; Stingl G
    J Invest Dermatol; 1991 Jul; 97(1):73-9. PubMed ID: 1711550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different growth properties in response to epidermal growth factor and interleukin-6 of primary keratinocytes derived from normal and psoriatic lesional skin.
    Oyama N; Sekimata M; Nihei Y; Iwatsuki K; Homma Y; Kaneko F
    J Dermatol Sci; 1998 Jan; 16(2):120-8. PubMed ID: 9459124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of transforming growth factor alpha in psoriatic epidermis.
    Elder JT; Fisher GJ; Lindquist PB; Bennett GL; Pittelkow MR; Coffey RJ; Ellingsworth L; Derynck R; Voorhees JJ
    Science; 1989 Feb; 243(4892):811-4. PubMed ID: 2916128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokines in skin lesions of psoriasis.
    Gearing AJ; Fincham NJ; Bird CR; Wadhwa M; Meager A; Cartwright JE; Camp RD
    Cytokine; 1990 Jan; 2(1):68-75. PubMed ID: 2104215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of cytokines and their receptors by psoriatic fibroblast. I. Altered IL-6 synthesis.
    Debets R; Hegmans JP; Deleuran M; Hooft S; Benner R; Prens EP
    Cytokine; 1996 Jan; 8(1):70-9. PubMed ID: 8742069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.
    Rømer J; Hasselager E; Nørby PL; Steiniche T; Thorn Clausen J; Kragballe K
    J Invest Dermatol; 2003 Dec; 121(6):1306-11. PubMed ID: 14675174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclophilin content of normal and psoriatic epidermis.
    Griffiths CE; Fisher GJ; Harding MW; Elder JT; Voorhees JJ
    J Invest Dermatol; 1990 Apr; 94(4):436-40. PubMed ID: 2179418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor.
    Kim NI; Cooper KD; Fisher GJ; Baadsgaard O; Voorhees JJ; Hammerberg C
    Arch Dermatol Res; 1992; 284(2):71-6. PubMed ID: 1610215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells.
    Cai JP; Falanga V; Taylor JR; Chin YH
    J Invest Dermatol; 1992 Apr; 98(4):405-9. PubMed ID: 1548425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.